Open AccessCorrection: Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway
Author(s) -
Brendan D. Looyenga,
James H. Resau,
Jeffrey P. MacKeigan
Publication year - 2014
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/annotation/7a99f22f-8273-43c0-b78f-8675ee409bf6
Subject(s) - glycoprotein 130 , hydroxydopamine , signal transduction , suppressor of cytokine signalling , cytokine receptor , cytokine , jak stat signaling pathway , chemistry , microbiology and biotechnology , biology , cancer research , socs3 , endocrinology , immunology , receptor tyrosine kinase , stat3 , dopaminergic , dopamine